YDESWYD Bio Limited Warrants

0.4100USD+10.81%Mkt Cap: —P/E: —3d ago

YD Bio Limited a biopharmaceutical company focuses on blood-based cancer detection and develops stem cell- and exosome-based therapeutics to transform the treatment of spectrum of diseases with unmet medical needs. The c…

Key Statistics

Company

Market Cap—

Enterprise Value—

Revenue (TTM)510.36K $

Gross Profit167.41K $

Net Income (TTM)-8.31M $

Revenue/Share0.4660 USD

Last Price0.4100 USD

Fiscal Year End—

MR Quarter—

Employees—

CountryUS

Sector—

Industry—

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA—

EV/Revenue—

P/S—

P/B0.08

EPS (TTM)—

EPS (Forward)—

52W Range

0.191339% of range0.7500

52W High0.7500 USD

52W Low0.1913 USD

Profitability

Gross Margin28.05%

Oper. Margin-444.59%

EBITDA Margin-265.93%

Profit Margin-1392.61%

ROE291.05%

ROA-60.32%

Growth

Revenue Growth95.60%

Earnings Growth—

Cash Flow & Leverage

Operating CF-6.60M $

CapEx (TTM)1.44M $

FCF Margin-759.38%

FCF Yield—

Net Debt-3.11M $

Net Debt/EBITDA2.29

Balance Sheet

Debt/Equity-0.00

Current Ratio13.18

Quick Ratio12.91

Book Value/Sh4.571 USD

Cash/Share2.173 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.—

Float319.74K

Insiders—

Institutions—

Technical

SMA 50—

SMA 200—

Beta-0.13

S&P 52W Chg18.16%

Avg Vol (30d)3.29K

Avg Vol (10d)—

Technical Indicators

RSI (14)44.6

MACD-0.0962

MACD Signal-0.0830

MACD Hist.-0.0132

BB Upper0.9510 USD

BB Middle0.5247 USD

BB Lower0.0984 USD

BB Width162.48%

ATR (14)0.0878 USD

Vol Ratio (20d)0.21x